SCHEMBL6235936

SCHEMBL6235936

Cc1cccc(Oc2ccc3c(c2)Cc2sc(N)nc2-3)c1

nearest known ligand 0.66

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 18/20 0.66
CHEK1 O14757 1/20 0.52
DAPK3 O43293 1/20 0.52
LTK P29376 1/20 0.52
MAPK8 P45983 1/20 0.52
CSNK1A1 P48729 1/20 0.52
CDK8 P49336 1/20 0.52
LIMK1 P53667 1/20 0.52
CDK5 Q00535 1/20 0.52
DYRK1A Q13627 1/20 0.52
LRRK2 Q5S007 1/20 0.52
CLK4 Q9HAZ1 1/20 0.52
DYRK1B Q9Y463 1/20 0.52
MAPT P10636 1/20 0.50
THRB P10828 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7655102 0.99 ADORA1 (0.65) ADORA1CHEK1DAPK3LTKMAPK8
Iodide SCHEMBL3989936 0.81 ADORA1 (0.83) ADORA1CHEK1DAPK3LTKMAPK8
Iodide SCHEMBL3994593 0.80 ADORA1 (1.00) ADORA1CHEK1DAPK3LTKMAPK8
Iodide SCHEMBL3994608 0.79 ADORA1 (0.74) ADORA1
SCHEMBL3988964 0.76 ADORA1 (0.69) ADORA1CHEK1DAPK3LTKMAPK8
Iodide SCHEMBL4594378 0.75 ADORA1 (1.00) ADORA1
Iodide SCHEMBL3994600 0.75 ADORA1 (1.00) ADORA1CHEK1DAPK3LTKMAPK8
Iodide SCHEMBL3993066 0.73 ADORA1 (1.00) ADORA1MAPT
SCHEMBL5573260 0.71 ADORA1 (0.67) ADORA1CHEK1DAPK3LTKMAPK8
SCHEMBL7292556 0.70 RAB9A (0.74) MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1157015-B1 USE OF POLYCYCLIC 2-AMINO-THIAZOLE SYSTEMS FOR THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT OF LIPOMETABOLIC DISORDERS, OBESITAS AND TYP II DIABETES AVENTIS PHARMA GMBH (DE) 2005-05-11 EP disclosed
EP-1173176-B1 UTILIZATION OF POLYCYCLIC 2-AMINO-THIAZOLE SYSTEMS IN THE PRODUCTION OF MEDICAMENTS FOR PROPHYLAXIS OR TREATMENT OF OBESITY AVENTIS PHARMA GMBH (DE) 2004-05-26 EP disclosed
EP-1173176-A1 UTILIZATION OF POLYCYCLIC 2-AMINO-THIAZOLE SYSTEMS IN THE PRODUCTION OF MEDICAMENTS FOR PROPHYLAXIS OR TREATMENT OF OBESITY Aventis Pharma Deutschland GmbH (DE) 2002-01-23 EP disclosed
EP-1157015-A1 POLYCYCLIC 2-AMINO-THIAZOLE SYSTEMS, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENT CONTAINING SAID COMPOUNDS Aventis Pharma Deutschland GmbH (DE) 2001-11-28 EP disclosed
WO-2000051602-A1 UTILIZATION OF POLYCYCLIC 2-AMINO-THIAZOLE SYSTEMS IN THE PRODUCTION OF MEDICAMENTS FOR PROPHYLAXIS OR TREATMENT OF OBESITY AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-09-08 WO disclosed
WO-2000051995-A1 POLYCYCLIC 2-AMINO-THIAZOLE SYSTEMS, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENT CONTAINING SAID COMPOUNDS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-09-08 WO disclosed